Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?
Year of publication: |
2024
|
---|---|
Authors: | Cook, Amanda C. ; Sirmans, E. Tice ; Wells, Brenda |
Published in: |
The Geneva papers on risk and insurance - issues and practice. - Basingstoke : Palgrave Macmillan, ISSN 1468-0440, ZDB-ID 2063785-8. - Vol. 49.2024, 1, p. 212-226
|
Subject: | Health Insurance | Medical Cannabis | Perscription Drug Expenditure | Arzneimittel | Pharmaceuticals | Drogenkonsum | Drug consumption | Gesundheitskosten | Health care costs | Private Krankenversicherung | Private health insurance | Drogenpolitik | Drug policy | Krankenversicherung | Health insurance | Osteuropa | Eastern Europe | Cannabis |
-
Alfrey, Brett, (2024)
-
Differential effects by mental health status of filling the Medicare part d coverage gap
Liu, Judith, (2020)
-
The impact of income-related medicare part b premiums on labor supply
Ayyagari, Padmaja, (2021)
- More ...
-
Random effects probit and logit : understanding predictions and marginal effects
Bland, James R., (2019)
-
Restrictive Rating and Adverse Selection in Health Insurance
Born, Patricia H., (2019)
-
Regret in health insurance postāpurchase behavior
Born, Patricia H., (2019)
- More ...